NSAIDs and covid-19: What have we learned?
Article written by Christine Clark In the early days of the coronavirus pandemic there was concern that the use of non-steroidal anti-inflammatory drugs might be harmful and people… read more.
Article written by Christine Clark In the early days of the coronavirus pandemic there was concern that the use of non-steroidal anti-inflammatory drugs might be harmful and people… read more.
Article written by Christine Clark The similarities between the ACE-inhibitor cough and the cough of covid-19 prompted Dr Colin Brown, a retired GP and researcher, to investigate further…. read more.
Article written by Christine Clark The similarities between the ACE-inhibitor cough and the cough of covid-19 prompted Dr Colin Brown, a retired GP and researcher, to investigate further…. read more.
Article written by Christine Clark Retired GP and researcher Dr Colin Brown realised that the similarities between the ACEI cough and covid-19 cough suggested a common cause and… read more.
With the outbreak of the Pandemic and the lingering worries of COVID-19 pharmaceutical sales and marketing has taken a hit. There are no live conferences that health care… read more.
Article written by Bruce Sylvester Among patients with a history of heart problems, prediabetes increases risks of heart disease and death, researchers reported on July 15, 2020 in… read more.
One in four older Americans had a virtual medical visit in the first three months of the COVID-19 pandemic, most of them by video, a new telehealth poll finds.
Article written by Gary Finnegan China’s control measures during the first 50 days of the COVID-19 epidemic may have delayed the spread of the virus to cities outside… read more.
Article written by Bruce Sylvester. Current smokers and those with chronic obstructive pulmonary disease COPD suffer greater COVID-19 severity and greater COVID-19 related mortality..
AstraZeneca announced high-level results from Farxiga’s (dapagliflozin) Phase III DAPA-CKD trial showed a statistically significant and clinically meaningful effect on its primary endpoint of a composite of worsening… read more.
Pfizer Inc. and BioNTech SE announced the start of a global (except for China) Phase II/III safety and efficacy clinical study to evaluate a single nucleoside-modified messenger RNA… read more.
Health Canada has approved, with conditions, remdesivir (Velkury) from Gilead Sciences to treat COVID-19 patients. Remdesivir is used to treat those with pneumonia who need extra oxygen to… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.